Broadcast Ad Preclearance Discussions Wanted By Networks -- Glaxo Exec
Executive Summary
Network television placements for direct-to-consumer prescription drug ads can be difficult without correspondence from FDA indicating the initiation of preclearance discussions between the agency and sponsor, a Glaxo exec said.
You may also be interested in...
DTC Ads Fall Outside "Learned Intermediary" Protections, N.J. Court Rules
Direct-to-consumer advertising modifies the "learned intermediary" doctrine, the New Jersey Supreme Court declared in an Aug. 9 ruling concerning Wyeth-Ayerst's promotion of its contraceptive Norplant.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011